Post in Request for Information (RFI): FY 2021-2025 Strategic Plan for the Office of Research Infrastructure (ORIP), NIH

Yes, we should.  S10 grants fall under this RFI.  I think we should also
respond to ”training the next generations of researchers" that it should
include training of core personnel.  NCI has an R50 mechanism for this purpose
but expanding to non-cancer would help more institutions.

Rest of post

Kat

------------
Director, Institutional Shared Resources
MD Anderson Cancer Center
And yes, I do understand that MD Anderson has access to R50s so we are covered.

-----Original Message-----
From: Core Administrators Network Forum <email obscured>> On Behalf Of
Philip E Hockberger
Sent: Friday, January 24, 2020 9:00 AM
To: Core Administrators Network Forum <email obscured>>; Andrew Chitty
<email obscured>>
Cc: <email obscured>
Subject: [EXT] [core administrators network forum] FW: Request for Information
(RFI): FY 2021-2025 Strategic Plan for the Office of Research Infrastructure
(ORIP), NIH

WARNING: This email originated from outside of MD Anderson. Please validate the
sender's email address before clicking on links or attachments as they may not
be safe.

Is this something the CAN-CC should lead on behalf of the ABRF?

From: "Vonkollmar, Desiree (NIH/OD) [E]" <email obscured>>
Reply-To: "Klosek, Malgorzata (NIH/OD) [E]" <email obscured>>
Date: Friday, January 24, 2020 at 8:55 AM
To: "Vonkollmar, Desiree (NIH/OD) [E]" <email obscured>>
Cc: "Klosek, Malgorzata (NIH/OD) [E]" <email obscured>>
Subject: Request for Information (RFI): FY 2021-2025 Strategic Plan for the
Office of Research Infrastructure (ORIP), NIH

Dear Colleague,

We Need your Help!

The Office of Research Infrastructure Programs (ORIP) is seeking your input.

As part of ORIP’s strategic planning process, we have released a request for
information (RFI),
NOT-OD-20-050<https://urldefense.proofpoint.com/v2/url?u=https-3A__grants.nih.gov_grants_guide_notice-2Dfiles_NOT-2DOD-2D20-2D050.html&d=DwMFAg&c=yHlS04HhBraes5BQ9ueu5zKhE7rtNXt_d012z2PA6ws&r=pUPklN0DJ6oAKPqkNq7WFAyhC_dCYGb4L1B1h5d8_ws&m=uY5cyrchPMcCD0cj4nivgAs_ZfuOZW0IPApFvNKhpE4&s=c8cBq6LSGezD-yyJUVfRIdIME0jq8UXvWDgSdZSI8bQ&e=>:
“FY 2021-2025 Strategic Plan for the Office of Research Infrastructure
Programs: Division of Comparative Medicine and Division of Construction and
Instruments Programs.”

ORIP<https://urldefense.proofpoint.com/v2/url?u=https-3A__orip.nih.gov_&d=DwMFAg&c=yHlS04HhBraes5BQ9ueu5zKhE7rtNXt_d012z2PA6ws&r=pUPklN0DJ6oAKPqkNq7WFAyhC_dCYGb4L1B1h5d8_ws&m=uY5cyrchPMcCD0cj4nivgAs_ZfuOZW0IPApFvNKhpE4&s=pY1Dm6S-tmPo28Tj126G8uGV-ji89-rezZXL_kNLuoA&e=>,
located within the NIH’s Office of the Director, supports research
infrastructure resources for


  *   models of human diseases;
  *   the acquisition of cutting-edge scientific instruments;
  *   construction and modernization of research facilities;
  *   and training the next generations of researchers
through the Division of Comparative Medicine and the Division of Construction
and Instruments Programs.

This RFI seeks input from the research community and other interested
stakeholders about ORIP’s future directions and program priorities.

This RFI will be open for comments through February 7, 2020.

Please consider responding to this RFI and also sharing information about the
publication of this RFI with your colleagues.

Sincerely,

Malgorzata Klosek PhD
Director, Division of Construction and Instruments Office of Research
Infrastructure Programs Division of Program Coordination, Planning, and
Strategic Initiatives Office of the Director, National Institutes of Health
6701 Democracy Blvd
Bethesda, MD 20892-4877

Telephone: 301-435-0766
FAX: 301-480-3819
Email: <email obscured><email obscured>>



――
View topic http://list.abrf.org/r/topic/7kRJGJTEQj2TILHkGfFnqt
Leave group <email obscured>?Subject=Unsubscribe

The information contained in this e-mail message may be privileged,
confidential, and/or protected from disclosure. This e-mail message may contain
protected health information (PHI); dissemination of PHI should comply with
applicable federal and state laws. If you are not the intended recipient, or an
authorized representative of the intended recipient, any further review,
disclosure, use, dissemination, distribution, or copying of this message or any
attachment (or the information contained therein) is strictly prohibited. If
you think that you have received this e-mail message in error, please notify
the sender by return e-mail and delete all references to it and its contents
from your systems.